Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

OSTEOARTHRITIS

Going for gold to improve anti-NGF therapy in OA

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

Original article

  1. Au, M. T. et al. Nerve growth factor-targeted molecular theranostics based on molybdenum disulfide nanosheet-coated gold nanorods (MoS2-AuNR) for osteoarthritis pain. ACS Nano https://doi.org/10.1021/acsnano.1c02454 (2021)

    Article  PubMed  Google Scholar 

Related article

  1. Wise, B. L. et al. The evolution of nerve growth factor inhibition in clinical medicine. Nat. Rev. Rheumatol. 17, 34–46 (2021)

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Joanna Clarke.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Clarke, J. Going for gold to improve anti-NGF therapy in OA. Nat Rev Rheumatol 17, 508 (2021). https://doi.org/10.1038/s41584-021-00670-7

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing